Skip to main content
logo
AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.2987
+0.0057 (1.95%)
Aug 3, 2026, 10:22 AM EDT - Market open

AEON Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '22 Dec '21
Net Income
-60.11-39.2242.016.388.2
Depreciation & Amortization
0.080.080.1--
Stock-Based Compensation
5.525.326.25--
Other Adjustments
27.2123.46-69.35-10.58-10.14
Changes in Accounts Payable
-0.96-4.972.52--
Changes in Accrued Expenses
0.53-2.21-1.421.990.61
Changes in Income Taxes Payable
---0.320.2
Changes in Other Operating Activities
0.620.23-0.390.92-0.37
Operating Cash Flow
-12.04-17.31-20.29-0.98-1.49
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '22 Dec '21
Capital Expenditures
--0---
Purchases of Investments
-----276
Other Investing Activities
---0.4-
Investing Cash Flow
--0-0.4-276

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '22 Dec '21
Long-Term Debt Issued
--150.150.14
Long-Term Debt Repaid
-----0.07
Net Long-Term Debt Issued (Repaid)
--150.150.06
Issuance of Common Stock
1.8320.310.15-278.3
Net Common Stock Issued (Repurchased)
1.8320.310.15-278.3
Other Financing Activities
-----0.37
Financing Cash Flow
7.8320.3115.150.15277.99

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '22 Dec '21
Net Cash Flow
-4.22.99-5.15-0.430.5

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '22 Dec '21
Free Cash Flow
-12.04-17.31-20.29-0.98-1.49
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-0.63-1.74-35.23-0.51-0.00
Levered Free Cash Flow
-59.84-46.0957.819.758.7
Unlevered Free Cash Flow
-12.08-19.6773.790.31-1.49
SEC Filings: 10-K · 10-Q